Reveragen Biopharma, Inc
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- May 16, 2017 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 98 Total Citation Count
- May 28, 2009 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0375,037 NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF DISEASEJun 29, 16Dec 29, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9649320 Non-hormonal steroid modulators of NF-κB for treatment of diseaseAug 05, 16May 16, 17[A61K, C07J]
9637738 Methods and agents to increase therapeutic dystrophin expression in muscleApr 10, 14May 02, 17[A61K, C12N]
9434758 Non-hormonal steroid modulators of NF-κB for treatment of diseaseJan 27, 14Sep 06, 16[A61K, C07J]
9198921 Non-hormonal steroid modulators of NF-κB for treatment of diseaseApr 05, 11Dec 01, 15[A61K, C07J]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.